GREENLAND MINES LTD Other Current Liabilities
GREENLAND MINES LTD (GRML) had Other Current Liabilities of $22.10 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-05-15
- 2025-03-31: Other Liabilities, Current $22.10K.
- 2024-09-30: Other Liabilities, Current $151.00K.
- 2024-06-30: Other Liabilities, Current $15.06K.
- 2024-03-31: Other Liabilities, Current $347.05K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-03-31 | $22.10K 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $151.00K 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $15.06K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $347.05K 10-Q · filed 2024-05-23 | |
| 2023-12-31 | $159.00K 10-Q · filed 2024-11-19 | $65.00K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |